Trials / Unknown
UnknownNCT05350020
The Effects of Two Brands of Hydrocortisone Injected Intramuscularly Into Deltoid and Thigh Muscles
An Open Label Pilot Study to Investigate the Effects of Two Preparations of Hydrocortisone (Hydrocortisone 100mg/ml and Solu-Cortef) Injected Intramuscularly Into the Deltoid and Upper Thigh Muscle During the State of Hypocortisolaemia
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- Sponsor
- The London Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study will be looking at the cortisol profiles of hypocortisolaemic patients following 100mg injections of two hydrocortisone preparations (Solu-Cortef® \& Hydrocortisone 100mg/ml). The investigators plan to use two methods of intramuscular injection to administer the preparations, one using a 1inch orange needle into the deltoid muscle and the other using a 1.25inch blue needle into the thigh muscle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Solu-Cortef 100 MG Injection | Licensed medicine used in clinical practice. Preparations will be used unmodified in this trial withinmarketing authorisations. |
| DRUG | Hydrocortisone 100mg/ml | Licensed medicine used in clinical practice. Preparations will be used unmodified in this trial within marketing authorisations. |
Timeline
- Start date
- 2022-03-14
- Primary completion
- 2023-03-01
- Completion
- 2023-08-01
- First posted
- 2022-04-27
- Last updated
- 2022-04-27
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05350020. Inclusion in this directory is not an endorsement.